Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
m2p-labs Launches Next Generation of Controlled Microbioreactors
Wednesday, October 09, 2013
Company has launched BioLector® Pro at the BIOTECHNICA fair in Hannover.

MicroAqua: A 12 Party Consortium Drives the Development of a Microarray
Monday, September 09, 2013
Scienion technology used for multiparameter testing to enable biohazard detection in water.

Vishay Launches TANTAMOUNT® Solid Tantalum Chip Capacitors
Thursday, August 22, 2013
Reliable molded capacitors combine robust anode design with Weibull grading and Hi-Rel screening options.

Cronus Technologies Launches the Handyem HPC-100 Portable Flow Cytometer
Wednesday, August 14, 2013
Company launches HPC-100 at Flow Cytometry UK 2013.

Fluidigm and Olink Bioscience Bring New Level of Protein Biomarker Discovery
Friday, August 02, 2013
96 samples across 92 proteins in one microfluidic run.

Thermo Fisher Scientific Expands Water Purification Portfolio
Thursday, August 01, 2013
Advanced dispensing technology increases flexibility and ease-of-use for shared lab environments.

Malvern Instruments Launches Viscosizer 200 - a New Analytical Instrument for Biopharmaceutical Development
Thursday, August 01, 2013
Automated viscosity and molecular sizing using less than 10 µL sample.

Measure Molecular Size of Proteins & Polymers
Tuesday, July 23, 2013
Easy and fast measurement of intrinsic viscosity with m-VROC.

Dolomite Presents New Range of Piezoelectric Pumps
Wednesday, July 17, 2013
High performance in miniature format.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 1043
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed